The Cigna Group (CI): A Bull Case Theory
We came across a bullish thesis on The Cigna Group (CI) on Antonio Linares’ Substack. In this article, we will summarize the bulls’ thesis on CI.
Cigna Group (CI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | GQG Partners Rajiv Jain | 4,886,674 | $1,607,715,699 | +22% | 2.56% |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 2,016,695 | $663,492,655 | +16% | 0.54% |
| 3. | AQR Capital Management Cliff Asness | 1,149,693 | $378,249,033 | +16% | 0.39% |
| 4. | 1,124,000 | $369,796,000 | -2% | 22.93% | |
| 5. | Lyrical Asset Management Andrew Wellington And Jeff Keswin | 800,287 | $263,294,423 | -1% | 4% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $211.59 | 500 | Director | 26,202 | 2021-08-11 | Filing | |
| $209.89 | 500 | Director | 25,702 | 2021-08-10 | Filing | |
| $168.77 | 1,000 | Officer | 26,555 | 2020-09-11 | Filing | |
| $187.37 | 5,460 | Director | 31,642 | 2020-06-15 | Filing | |
| $195.04 | 4,100 | Director | 25,683 | 2019-12-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $310.35 | 2,376 | Director | 5,471 | 2025-03-14 | Filing | |
| $320.00 | 9,944 | Officer | 13,406 | 2025-03-07 | Filing | |
| $308.12 | 26,527 | Officer, Director | 127,767 | 2025-03-03 | Filing | |
| $308.12 | 4,904 | Officer | 29,421 | 2025-03-03 | Filing | |
| $342.68 | 2,691 | Director | 17,539 | 2024-08-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 26,154,490 | $8,604,827,210 | 0.16% | |
| 2. | 24,115,351 | $7,933,950,615 | 0.17% | |
| 3. | 13,322,069 | $4,382,961,046 | 0.28% | |
| 4. | 12,470,088 | $4,102,658,952 | 0.17% | |
| 5. | 11,654,993 | $3,834,492,697 | 1.27% |
News See All
UBS Maintains Buy Rating on Cigna (CI) Stock
The Cigna Group’s (NYSE:CI) strategic departure from the Medicare Advantage (MA) business was highlighted.
Cigna Announced a New Agreement for Copay Caps on Eli Lilly and Novo Nordisk Weight Loss Drugs
The Cigna Group (NYSE:CI)'s Evernorth division has announced a new deal with Novo Nordisk and Eli Lilly that will limit insured customers' monthly out-of-pocket expenses for weight-loss drugs Zepbound...
11 Cheap ESG Stocks to Buy According to Hedge Funds
These days, it seems like everyone wants to wear the “saving the world” cape.
Cigna Corporation (NYSE:CI) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by for The Sector Group's First Quarter 2025 Results Review. At this time, callers are in a listen-only mode.
Jim Cramer is Bullish on These 10 Stocks
“You gotta make a list and decide what you can live with and what's simply too dicey to buy.
10 Best Healthcare Stocks to Buy According to Billionaires
Healthcare stocks experienced a challenging year in 2024, lagging behind high-growth sectors like tech and AI.
15 Best and Cheap Stocks to Buy According to Billionaires
Billionaire investor and CEO of Berkshire Hathaway Warren Buffett sold a record $134 billion worth of stock in 2024. Buffett’s move is considered a benchmark among investors to assess the market.
10 Best Undervalued Stocks to Buy According to Billionaires
Identifying undervalued stocks in an uncertain market environment is both a challenge and an opportunity for investors.
The Cigna Group (CI) Fell amid Regulatory Concerns
Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Billionaire Hedge Funds
